404 408

Cited 106 times in

Role of the phosphatidylinositol-3-kinase and extracellular regulated kinase pathways in the induction of hypoxia-inducible factor (HIF)-1 activity and the HIF-1 target vascular endothelial growth factor in ovarian granulosa cells in response to follicle-stimulating hormone

DC Field Value Language
dc.contributor.author이은직-
dc.date.accessioned2015-04-24T16:34:30Z-
dc.date.available2015-04-24T16:34:30Z-
dc.date.issued2009-
dc.identifier.issn0013-7227-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/103770-
dc.description.abstractFSH stimulation of granulosa cells (GCs) results in increased hypoxia-inducible factor (HIF)-1alpha protein levels and HIF-1 activity that is necessary for up-regulation of certain FSH target genes including vascular endothelial growth factor. We report that the role of the phosphatidylinositol (PI)-3-kinase/AKT pathway in increasing HIF-1alpha protein in FSH-stimulated GCs extends beyond an increase in mammalian target of rapamycin-stimulated translation. FSH increases phosphorylation of the AKT target mouse double-minute 2 (MDM2); a phosphomimetic mutation of MDM2 is sufficient to induce HIF-1 activity. The PI3-kinase/AKT target forkhead box-containing protein O subfamily 1 (FOXO1) also effects the accumulation of HIF-1alpha as evidenced by the ability of a constitutively active FOXO1 mutant to inhibit the induction by FSH of HIF-1alpha protein and HIF-1 activity. Activation of the PI3-kinase/AKT pathway in GCs by IGF-I is sufficient to induce HIF-1alpha protein but surprisingly not HIF-1 activity. HIF-1 activity also appears to require a PD98059-sensitive protein (kinase) activity stimulated by FSH that is both distinct from mitogen-activated ERK kinase1/2 or 5 and independent of the PI3-kinase/AKT pathway. These results indicate that FSH-stimulated HIF-1 activation leading to up-regulation of targets such as vascular endothelial growth factor requires not only PI3-kinase/AKT-mediated activation of mammalian target of rapamycin as well as phosphorylation of FOXO1 and possibly MDM2 but also a protein (kinase) activity that is inhibited by the classic ERK kinase inhibitor PD98059 but not ERK1/2 or 5. Thus, regulation of HIF-1 activity in GCs by FSH under normoxic conditions is complex and requires input from multiple signaling pathways.-
dc.description.statementOfResponsibilityopen-
dc.format.extent915~928-
dc.relation.isPartOfENDOCRINOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAnimals-
dc.subject.MESHCells, Cultured-
dc.subject.MESHExtracellular Signal-Regulated MAP Kinases/physiology*-
dc.subject.MESHFemale-
dc.subject.MESHFollicle Stimulating Hormone/pharmacology*-
dc.subject.MESHForkhead Transcription Factors/antagonists & inhibitors-
dc.subject.MESHGranulosa Cells/drug effects*-
dc.subject.MESHGranulosa Cells/metabolism-
dc.subject.MESHHypoxia-Inducible Factor 1/metabolism*-
dc.subject.MESHInsulin-Like Growth Factor I/pharmacology-
dc.subject.MESHNerve Tissue Proteins/antagonists & inhibitors-
dc.subject.MESHOvary/drug effects*-
dc.subject.MESHOvary/metabolism-
dc.subject.MESHPhosphatidylinositol 3-Kinases/physiology*-
dc.subject.MESHPhosphorylation/drug effects-
dc.subject.MESHProtein Kinases/physiology-
dc.subject.MESHProto-Oncogene Proteins c-mdm2/metabolism-
dc.subject.MESHRats-
dc.subject.MESHRats, Sprague-Dawley-
dc.subject.MESHSignal Transduction/drug effects-
dc.subject.MESHSignal Transduction/physiology-
dc.subject.MESHTOR Serine-Threonine Kinases-
dc.subject.MESHVascular Endothelial Growth Factor A/genetics-
dc.subject.MESHVascular Endothelial Growth Factor A/metabolism*-
dc.titleRole of the phosphatidylinositol-3-kinase and extracellular regulated kinase pathways in the induction of hypoxia-inducible factor (HIF)-1 activity and the HIF-1 target vascular endothelial growth factor in ovarian granulosa cells in response to follicle-stimulating hormone-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학)-
dc.contributor.googleauthorHena Alam-
dc.contributor.googleauthorJennifer Weck-
dc.contributor.googleauthorEvelyn Maizels-
dc.contributor.googleauthorYoungkyu Park-
dc.contributor.googleauthorEun Jig Lee-
dc.contributor.googleauthorMargaret Ashcroft-
dc.contributor.googleauthorMary Hunzicker-Dunn-
dc.identifier.doi10.1210/en.2008-0850-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA03050-
dc.relation.journalcodeJ00772-
dc.identifier.eissn1945-7170-
dc.identifier.pmid18845636-
dc.contributor.alternativeNameLee, Eun Jig-
dc.contributor.affiliatedAuthorLee, Eun Jig-
dc.citation.volume150-
dc.citation.number2-
dc.citation.startPage915-
dc.citation.endPage928-
dc.identifier.bibliographicCitationENDOCRINOLOGY, Vol.150(2) : 915-928, 2009-
dc.identifier.rimsid36683-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.